**Core Concept**
Agranulocytosis is a potentially life-threatening reduction in white blood cells, particularly neutrophils, leading to increased susceptibility to infections. Certain medications can induce this condition by affecting the bone marrow's ability to produce blood cells. In this context, the focus is on identifying medications associated with an increased risk of agranulocytosis.

**Why the Correct Answer is Right**
Agranulocytosis is a rare but serious side effect of certain medications, including some antipsychotics, antibiotics, and antithyroid drugs. The mechanism involves the suppression of bone marrow function, leading to a decrease in neutrophil production. Medications that interfere with DNA synthesis or induce apoptosis in bone marrow cells can increase the risk of agranulocytosis.

**Why Each Wrong Option is Incorrect**
**Option A:** This medication is not commonly associated with agranulocytosis. While it does have hematologic side effects, agranulocytosis is not a well-documented risk.

**Option B:** This medication is not typically linked to agranulocytosis. Its side effect profile includes gastrointestinal and cardiovascular effects, but agranulocytosis is not a known risk.

**Option C:** This medication is associated with agranulocytosis due to its mechanism of action, which involves the suppression of bone marrow function.

**Option D:** This medication is not commonly associated with agranulocytosis. Its side effect profile includes dermatologic and musculoskeletal effects, but agranulocytosis is not a well-documented risk.

**Clinical Pearl / High-Yield Fact**
When prescribing medications with a known risk of agranulocytosis, it's essential to monitor patients closely for signs of infection and to obtain regular blood counts. Agranulocytosis can be a medical emergency, and prompt recognition and treatment are crucial to prevent serious complications.

**Correct Answer:** C. This medication is associated with an increased risk of agranulocytosis.